Sibutramine plus meal replacement therapy for body weight loss and maintenance in obese patients

Obesity

Volumn 15, Issue 6, 2007, Pages 1464-1472

  Early, James L ^a   Apovian, Caroline M ^b   Aronne, Louis J ^c   Fernstrom, Madelyn H ^d   Frank, Arthur ^e   Greenway, Frank L ^f   Heber, David ^g   Kushner, Robert F ^h   Cwik, Kristine M ⁱ   Walch, Julia K ⁱ   Hewkin, Ann C ⁱ   Blakesley, Vicky ⁱ  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE WICHITA   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^f PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h NORTHWESTERN UNIVERSITY   (United States)

ⁱ ABBOTT LABORATORIES   (United States)

Author keywords

Behavior modification; Clinical management; Meal replacement; Pharmacotherapy; Risk factor

Indexed keywords

ANOREXIGENIC AGENT; CYCLOBUTANE DERIVATIVE; PLACEBO; SIBUTRAMINE;

ADOLESCENT; ADULT; ALGORITHM; ARTICLE; BEHAVIOR THERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET THERAPY; DRUG EFFECT; ELEMENTAL DIET; HUMAN; LOW CALORY DIET; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; OBESITY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; WEIGHT REDUCTION;

ADOLESCENT; ADULT; ALGORITHMS; APPETITE DEPRESSANTS; BEHAVIOR THERAPY; COMBINED MODALITY THERAPY; CYCLOBUTANES; DIET, REDUCING; FOOD, FORMULATED; HUMANS; MIDDLE AGED; OBESITY; PLACEBOS; SINGLE-BLIND METHOD; WEIGHT LOSS;

EID: 34547166019     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2007.175     Document Type: Article

References (23)

1. Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343-50.
2. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393-403.
3. Pan XR, Li GW, Hu YH, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: the Da Qing IGT and Diabetes Study. Diabetes Care. 1997;20:537-44.
4. Stevens VJ, Corrigan SA, Obarzanek E, et al. Weight loss intervention in Phase 1 of the Trials of Hypertension Prevention: the TOHP Collaborative Research Group. Arch Intern Med. 1993;153:849-58.
5. Stevens VJ, Obarzanek E, Cook NR, et al. Long-term weight loss and changes in blood pressure: results of the Trials of Hypertension Prevention, Phase II. Ann Intern Med. 2001;134:1-11.
6. Avenell A, Broom J, Brown TJ, et al. Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement. Health Technol Assess. 2004;8:1-182.
7. Wood PD, Stefanick ML, Williams PT, Haskell WL. The effects on plasma lipoproteins of a prudent weight-reducing diet, with or without exercise, in overweight men and women. N Engl J Med. 1991;325:461-6.
8. Poobalan A, Aucott L, Smith WC, et al. Effects of weight loss in overweight/obese individuals and long-term lipid outcomes: a systematic review. Obes Rev. 2004;5:43-50.
9. Wadden TA, Sternberg JA, Letizia KA, Stunkard AJ, Foster GD. Treatment of obesity by very low calorie diet, behavior therapy, and their combination: a five-year perspective. Int J Obes. 1989;13(suppl):39-46.
10. Ditschuneit HH, Flechtner-Mors M, Johnson TD, Adler G. Metabolic and weight-loss effects of a long-term dietary intervention in obese patients. Am J Clin Nutr. 1999;69:198-204.
11. Heymsfield SB, van Mierlo CA, van der Knaap HC, Heo M, Frier HI. Weight management using a meal replacement strategy: meta and pooling analysis from six studies. Int J Obes Relat Metab Disord. 2003;27:537-49.
12. Keogh JB, Clifton PM. The role of meal replacements in obesity treatment. Obes Rev. 2005;6:229-34.
13. Ditschuneit HH, Flechtner-Mors M. Value of structured meals for weight management: risk factors and long-term weight maintenance. Obes Res. 2001;9(Suppl 4):284-9.
14. Quinn Rothacker D. Five-year self-management of weight using meal replacements: comparison with matched controls in rural Wisconsin. Nutrition. 2000;16:344-8.
15. Hansen DL, Toubro S, Stock MJ, Macdonald IA, Astrup A. Thermogenic effects of sibutramine in humans. Am J Clin Nutr. 1998;68:1180-6.
16. Walsh KM, Leen E, Lean ME. The effect of sibutramine on resting energy expenditure and adrenaline-induced thermogenesis in obese females. Int J Obes Relat Metab Disord. 1999;23:1009-15.
17. James WPT, Astrup A, Finer N, et al. Effect of sibutramine on weight maintenance after weight loss: a randomized trial (STORM). Lancet. 2000;356:2119-25.
18. Apfelbaum M, Vague P, Ziegler O, Hanotin C, Thomas F, Leutenegger E. Long-term maintenance of weight loss after a very-low-calorie diet: a randomized blinded trial of the efficacy and tolerability of sibutramine. Am J Med. 1999;106:179-84.
19. SAS Institute, Inc. SAS Users Guide: SAS Procedures Guide. Cary, NC: SAS Institute, Inc.; 1990.
20. Hauner H, Meier M, Wendland G, et al. Weight reduction by sibutramine in obese subjects in primary care medicine: the SAT study. Exp Clin Endocrinol Diabetes. 2004;112:201-7.
21. International Diabetes Federation. Consensus Worldwide Definition of the Metabolic Syndrome. http://www.idf.org/webdata/docs/MetS def FINAL.pdf (Accessed December 21, 2005).
22. Wing RR, Jeffery RW, Burton LR, Thorson C, Nissinoff KS, Baxter JE. Food provision vs. structured meal plans in the behavioral treatment of obesity. Int J Obes Relat Metab Disord. 1996;20:56-62.
23. Ryan DH, Espeland MA, Foster GD, et al. Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes. Control Clin Trials. 2003;24: 610-28.